Fideuram Asset Management Ireland dac Invests $1.06 Million in Stevanato Group S.p.A. $STVN

Fideuram Asset Management Ireland dac acquired a new position in shares of Stevanato Group S.p.A. (NYSE:STVN) in the 4th quarter, HoldingsChannel reports. The fund acquired 52,564 shares of the company’s stock, valued at approximately $1,058,000.

Several other large investors also recently modified their holdings of the stock. First Bank & Trust grew its position in shares of Stevanato Group by 5.6% during the 4th quarter. First Bank & Trust now owns 17,109 shares of the company’s stock worth $344,000 after buying an additional 904 shares during the period. Pathstone Holdings LLC grew its position in Stevanato Group by 1.5% in the 3rd quarter. Pathstone Holdings LLC now owns 71,178 shares of the company’s stock valued at $1,833,000 after purchasing an additional 1,067 shares during the period. Van Berkom & Associates Inc. grew its position in Stevanato Group by 50.6% in the 3rd quarter. Van Berkom & Associates Inc. now owns 3,615 shares of the company’s stock valued at $93,000 after purchasing an additional 1,215 shares during the period. Mariner LLC grew its position in Stevanato Group by 6.9% in the 3rd quarter. Mariner LLC now owns 25,447 shares of the company’s stock valued at $655,000 after purchasing an additional 1,638 shares during the period. Finally, Diversified Trust Co. grew its position in Stevanato Group by 12.5% in the 4th quarter. Diversified Trust Co. now owns 16,200 shares of the company’s stock valued at $326,000 after purchasing an additional 1,800 shares during the period.

Stevanato Group Stock Performance

NYSE STVN opened at €18.70 on Friday. The company has a fifty day simple moving average of €16.00 and a 200 day simple moving average of €17.96. Stevanato Group S.p.A. has a 12-month low of €12.89 and a 12-month high of €28.00. The company has a current ratio of 1.63, a quick ratio of 1.11 and a debt-to-equity ratio of 0.21. The company has a market cap of $5.66 billion, a P/E ratio of 31.70, a PEG ratio of 1.72 and a beta of 0.75.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings data on Friday, May 8th. The company reported €0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). The firm had revenue of €273.57 million for the quarter. Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.Stevanato Group’s revenue was up 6.6% on a year-over-year basis. During the same quarter last year, the company earned $0.10 earnings per share. Sell-side analysts predict that Stevanato Group S.p.A. will post 0.68 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on STVN. KeyCorp reduced their price target on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a research report on Thursday, March 5th. Wall Street Zen downgraded shares of Stevanato Group from a “buy” rating to a “hold” rating in a research report on Saturday, February 14th. Weiss Ratings downgraded shares of Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 11th. Jefferies Financial Group set a $17.50 price target on shares of Stevanato Group in a research report on Tuesday, February 10th. Finally, Morgan Stanley reduced their price target on shares of Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, March 6th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold”.

Stevanato Group Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.